Obat Medicare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.80 M
About Obat Medicare
Obat Medicare Private Limited (OMPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 June 2010 and has a history of 14 years and eight months. Its registered office is in Patna, Bihar, India.
The Corporate was formerly known as Balaji Adven Outfit Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.80 M.
Nil Maskara and Ayush Maskara serve as directors at the Company.
Company Details
- Location
Patna, Bihar, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74900BR2010PTC052897
- Company No.
204096
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
What products or services does Obat Medicare Private Limited offer?
Obat Medicare Private Limited offers a wide range of products and services, including Skin Care, Sunscreen Products.
Who are the key members and board of directors at Obat Medicare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ayush Maskara  | Director | 08-Mar-2017 | Current |
| Nil Maskara | Director | 25-Mar-2016 | Current |
Financial Performance of Obat Medicare.
Obat Medicare Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Obat Medicare?
In 2017, Obat Medicare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dermatist Consumer LlpAyush Maskara is a mutual person
Charges (Loans)
₹1.80 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.18 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Feb 2022 | Hdfc Bank Limited | ₹1.80 M | Open |
How Many Employees Work at Obat Medicare?
Unlock and access historical data on people associated with Obat Medicare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Obat Medicare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Obat Medicare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
